National Research Corporation

National Research Corporation (NASDAQ:NRCIA and NRCIB) creates real-time profiles focused on healthcare customers' experiences, risks, preferences, and behaviors. These analytics offer a rich understanding of patients who are inside and outside of healthcare settings, empowering providers to better predict, manage, and deliver customer-centric healthcare across the continuum. 

For more than 30 years, National Research has been at the forefront of patient-centered care. Today, the company’s focus on customer-centric healthcare transcends patient-centered care to incorporate families, communities, employees, and other stakeholders. 

Currently recognized by Modern Healthcare as the largest patient satisfaction measurement firm in the U.S., National Research is dedicated to representing the true voice of patients and other healthcare stakeholders. This integration of cross-continuum metrics and analytics uncovers insights for effective performance improvement, quality measurement, care transitions, and many other factors that impact population health management. 

Company Growth (employees)
Lincoln, US
Size (employees)
372 (est)+8%
National Research Corporation was founded in 1985 and is headquartered in Lincoln, US

National Research Corporation Office Locations

National Research Corporation has offices in Lincoln, Seattle, Atlanta, Markham and in 1 other location
Lincoln, US (HQ)
1245 Q St.
San Diego, US
9685 Via Excelencia, Suite 100
Markham, CA
7100 Woodbine Avenue, Suite 411
Atlanta, US
3423 Piedmont Rd, Suite 475
Seattle, US
1425 4th Avenue, 6th Floor

National Research Corporation Metrics

National Research Corporation Financial Metrics

Revenue (2016)

$109.4 m

Revenue growth (2015-16), %


Net income (2016)

$20.5 m

Market capitalization (28-Apr-2017)

$1 b

Closing share price (28-Apr-2017)


Cash (31-Dec-2016)

$33 m
National Research Corporation's current market capitalization is $1 b.
National Research Corporation's revenue was reported to be $109.4 m in FY, 2016 which is a 7% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016


$92.6 m$98.8 m$102.3 m$109.4 m

Revenue growth, %


General and administrative expense

$25.2 m$25 m

Operating expense total

$67.8 m$70.5 m$75.9 m$78.2 m


$24.8 m$28.3 m$26.4 m$31.2 m

EBIT margin, %


Interest expense

$397 k$305 k($220 k)($190 k)

Interest income

$63 k$83 k$60 k$47 k

Pre tax profit

$24.5 m$28.1 m$27.4 m$31.4 m

Income tax expense

$9 m$9.9 m$9.8 m$10.8 m

Net Income

$15.5 m$18.2 m$17.6 m$20.5 m
FY, 2013FY, 2014FY, 2015FY, 2016


$22.1 m$40 m$42.1 m$33 m

Accounts Receivable


Current Assets

$36.5 m$53.2 m$56.1 m$47.1 m


$57.6 m$58.5 m$57.8 m$57.9 m

Total Assets

$111 m$129.5 m$129.1 m$120.6 m

Accounts Payable

$654 k$830 k$614 k$765 k

Dividends Payable

$18.4 m$4.2 m

Current Liabilities

$23.7 m$27.9 m$44.2 m$31.5 m

Common Stock

$25 k$25 k

Additional Paid-in Capital

$42.2 m$44.9 m$44.1 m$46.7 m

Retained Earnings

$58 m$73.7 m$65.3 m$71.5 m

Total Equity

$74.2 m$82.8 m

Financial Leverage

1.7 x1.5 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

$15.5 m$18.2 m$17.6 m$20.5 m

Depreciation and Amortization

$3.7 m$3.8 m$4.2 m

Accounts Receivable

$970 k$2.9 m($1.8 m)($1 m)


($535 k)

Accounts Payable

$331 k$163 k($224 k)($15 k)

Cash From Operating Activities

$19.3 m$26.2 m$21.9 m$26.8 m

Purchases of PP&E

($2.2 m)($2.5 m)($2.9 m)($4 m)

Cash From Investing Activities

($2.2 m)($5.7 m)($1.3 m)($3.8 m)

Long-term Borrowings

($2.1 m)($2.3 m)($2.3 m)($2.2 m)

Cash From Financing Activities

($2.8 m)($1.7 m)($16.9 m)($32.5 m)

Income Taxes Paid

$8.2 m$9.9 m$9.4 m$10 m

National Research Corporation Market Value History

National Research Corporation Online Presence

National Research Corporation News

National Research Corporation Company Life

You may also be interested in